# N-Acetylcysteine as an Adjuvant Therapy in Critically Ill COVID-19 Patients:

> **NCT05504655** · — · COMPLETED · sponsor: **Ain Shams University** · enrollment: 80 (actual)

## Conditions studied

- COVID-19 Pneumonia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05504655
- **Lead sponsor:** Ain Shams University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-01
- **Primary completion:** 2022-11-27
- **Final completion:** 2022-12-22
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2023-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05504655

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05504655, "N-Acetylcysteine as an Adjuvant Therapy in Critically Ill COVID-19 Patients:". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05504655. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*